Old Web
English
Sign In
Acemap
>
authorDetail
>
Bayarmagnai Weinstein
Bayarmagnai Weinstein
University at Albany, SUNY
Clinical trial
Clinical endpoint
Oncology
Cytokine release syndrome
Medicine
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EFFICACY AND SAFETY OF EXPERIMENTAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS VERSUS AXICABTAGENE CILOLEUCEL (YESCARTA) FOR THE TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: MATCHING ADJUSTED INDIRECT COMPARISONS AND SYSTEMATIC REVIEW
2021
Hematology, Transfusion and Cell Therapy
Bayarmagnai Weinstein
Bogdan Muresan
Sara Solano
Av Macedo
YoonJung Lee
Y. Su
Yeseul Ahn
Cristina Pires Camargo
Gwang-Jin Kim
David O. Carpenter
Show All
Source
Cite
Save
Citations (0)
Efficacy and Safety of Experimental Chimeric Antigen Receptor (CAR) T-cells versus Axicabtagene ciloleucel (Yescarta) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL): Matching Adjusted Indirect Comparisons (MAICs) and Systematic Review.
2021
medRxiv
Bayarmagnai Weinstein
Bogdan Muresan
Sara Solano
Antonio Vaz de Macedo
YoonJung Lee
Yu-Chen Su
Yeseul Ahn
Gabriela Henriquez
Cristina Camargo
Gwang-Jin Kim
David O. Carpenter
Show All
Source
Cite
Save
Citations (0)
Precision Mapping of COVID-19 Vulnerable Locales by Epidemiological and Socioeconomic Risk Factors, Developed Using South Korean Data.
2021
International Journal of Environmental Research and Public Health
Bayarmagnai Weinstein
Alan Ricardo da Silva
Dimitrios E. Kouzoukas
Tanima Bose
Gwang-Jin Kim
Paola Correa
Santhi Pondugula
YoonJung Lee
J. Kim
David O. Carpenter
Show All
Source
Cite
Save
Citations (7)
1